Usefulness of Pre-biopsy Multiparametric Magnetic Resonance Imaging and Clinical Variables to Reduce Initial Prostate Biopsy in Men with Suspected Clinically Localized Prostate Cancer
Abstract
Purpose:
We evaluated the usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to decrease initial prostate biopsies.
Materials and Methods:
We prospectively evaluated 351 consecutive men with prostate specific antigen between 2.5 and 20 ng/ml, and/or digital rectal examination suspicious for clinically localized disease. All men underwent pre-biopsy multiparametric magnetic resonance imaging and initial 14 to 29-core biopsy, including anterior sampling. Three definitions of significant cancer were defined based on Gleason score and cancer volume (percent positive core and/or maximum cancer length). The overall cohort was divided into men at low risk—prostate specific antigen less than 10 ng/ml and normal digital rectal examination, and high risk—prostate specific antigen 10 ng/ml or greater and/or abnormal digital rectal examination. We evaluated the frequency of significant cancer according to magnetic resonance imaging and risk categories. Clinical variables as significant cancer predictors were analyzed using logistic regression. The sensitivity, specificity, and positive and negative predictive values of magnetic resonance imaging were calculated with or without clinical variables for significant cancer.
Results:
The frequency of significant cancer in men with negative vs positive magnetic resonance imaging was 9% to 13% vs 43% to 50% in the low risk group and 47% to 51% vs 68% to 71% in the high risk group. In men at low risk with negative magnetic resonance imaging prostate volume was the only significant predictor of significant cancer. In the low risk group the negative predictive value for significant cancer of a combination of positive magnetic resonance imaging and lower prostate volume (less than 33 ml) was 93.7% to 97.5%.
Conclusions:
Pre-biopsy multiparametric magnetic resonance imaging along with prostate volume decreases the number of initial prostate biopsies by discriminating between significant cancer and other cancer in men with prostate specific antigen less than 10 ng/ml and normal digital rectal examination.
References
- 1 : Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol2008; 54: 601. Google Scholar
- 2 : Lead time and over diagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst2009; 101: 374. Google Scholar
- 3 : Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med2012; 367: 203. Google Scholar
- 4 : Complications following prostate needle biopsy requiring hospital admission or emergency department visits—experience from 1000 consecutive cases. BJU Int2012; 110: 369. Google Scholar
- 5 : Complications after prostate biopsy: data from SEER-Medicare. J Urol2011; 186: 1830. Link, Google Scholar
- 6 : ESUR prostate MR guidelines 2012. Eur Radiol2012; 22: 746. Google Scholar
- 7 : Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol2011; 59: 477. Google Scholar
- 8 : Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology2011; 261: 46. Google Scholar
- 9 : Is it time to consider a role for MRI before prostate biopsy?. Nat Rev Clin Oncol2009; 6: 197. Google Scholar
- 10 : Image guidance in the focal treatment of prostate cancer. Curr Opin Urol2012; 22: 328. Google Scholar
- 11 : Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study. J Urol2012; 187: 1247. Link, Google Scholar
- 12 : Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study. Urology2008; 72: 859. Google Scholar
- 13 : Usefulness of pre-biopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol2011; 196: W715. Google Scholar
- 14 : Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol2007; 52: 1663. Google Scholar
- 15 : The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol2005; 29: 1228. Google Scholar
- 16 : Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol2012; 62: 976. Google Scholar
- 17 : Active surveillance for low-risk prostate cancer: an update. Nat Rev Urol2011; 8: 312. Google Scholar
- 18 : Active surveillance for prostate cancer: progress and promise. J Clin Oncol2011; 29: 3669. Google Scholar
- 19 : Assessing individual risk for prostate cancer. J Clin Oncol2007; 25: 3582. Google Scholar
- 20 : Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol2011; 186: 1281. Link, Google Scholar
- 21 : Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol2012; 61: 177. Google Scholar
- 22 : Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol2013; 63: 125. Google Scholar
- 23 : Characterizing clinically significant prostate cancer using template prostate mapping biopsy. J Urol2011; 186: 458. Link, Google Scholar
- 24 : Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study. Urol Int2011; 87: 49. Google Scholar
- 25 : Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol2009; 55: 1. Google Scholar
- 26 : The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J Urol2008; 180: 548. Link, Google Scholar
- 27 : Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system. Am J Surg Pathol2012; 36: 838. Google Scholar
- 28 : The contemporary concept of significant versus insignificant prostate cancer. Eur Urol2011; 60: 291. Google Scholar
- 29 : Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging2010; 31: 625. Google Scholar
Department of Urology, Tokyo Medical and Dental University Graduate School and Department of Radiology, Ochanomizu Surugadai Clinic (CI), Tokyo, Japan
